MetaADEDB 2.0 @ LMMD
Azacitidine
(NMUSYJAQQFHJEW-KVTDHHQDSA-N)
Structure
SMILES
OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc(nc1=O)N
Type(s)
Approved; Investigational
ATC code(s)
L01BC07
Molecular Formula:
C8H12N4O5
Molecular Weight:
244.205
Log P:
-2.5868
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
4
TPSA:
143.72
CAS Number(s):
320-67-2
Synonym(s)
1.
Azacitidine
2.
Azacytidine
3.
5-Azacytidine
4.
NSC-102816
5.
Vidaza
6.
5 Azacytidine
7.
NSC 102816
8.
NSC102816
External Link(s)
MeSHD001374
PubChem Compound9444
BindingDB50424715
ChEBI2038
CHEMBLCHEMBL1489
DrugBankDB00928
DrugCentral25
IUPHAR/BPS Guide to PHARMACOLOGY6796
KEGGcpd:C11262
dr:D03021
Therapeutic Target DatabaseD09FAZ
ZINC3861768
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1PneumoniaFAERS: 302
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
2Febrile NeutropeniaFAERS: 238
Canada Vigilance: 12
Canada Vigilance
OFFSIDES
SIDER
US FAERS
3SepsisFAERS: 226
Canada Vigilance: 12
Canada Vigilance
SIDER
US FAERS
4InfectionFAERS: 223
Canada Vigilance: 7
Canada Vigilance
OFFSIDES
SIDER
US FAERS
5MYELODYSPLASTIC SYNDROMEFAERS: 212
Canada Vigilance: 48
Canada Vigilance
US FAERS
6ThrombocytopeniaFAERS: 207
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
7NeutropeniaFAERS: 201
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
8Disease ProgressionFAERS: 161
Canada Vigilance: 49
Canada Vigilance
OFFSIDES
US FAERS
9PancytopeniaFAERS: 126
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
10NauseaFAERS: 102
Canada Vigilance: 2
6178065CTD
SIDER
Canada Vigilance
US FAERS
11Septic ShockFAERS: 102
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
12VomitingFAERS: 88
Canada Vigilance: 2
6178065CTD
SIDER
Canada Vigilance
US FAERS
13Myelodysplastic syndrome transformationFAERS: 85
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
14FatigueFAERS: 71
Canada Vigilance: 6
Canada Vigilance
OFFSIDES
SIDER
US FAERS
15ConstipationFAERS: 70
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
16General physical health deteriorationFAERS: 69
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
17Respiratory FailureFAERS: 68
Canada Vigilance: 1
Canada Vigilance
US FAERS
18AstheniaFAERS: 56
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
19Injection Site ReactionFAERS: 54
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
20Cerebrovascular accidentFAERS: 47
Canada Vigilance: 3
Canada Vigilance
US FAERS
21White blood cell count decreasedFAERS: 47US FAERS
22Toxicity to various agentsFAERS: 45
Canada Vigilance: 1
Canada Vigilance
US FAERS
23Urinary tract infectionFAERS: 41SIDER
US FAERS
24Drug ineffectiveFAERS: 39
Canada Vigilance: 2
Canada Vigilance
US FAERS
25LeukopeniaFAERS: 35SIDER
US FAERS
26CellulitisFAERS: 34
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
27Therapy non-responderFAERS: 33
Canada Vigilance: 6
Canada Vigilance
US FAERS
28Neutrophil count decreasedFAERS: 32
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
29MalaiseFAERS: 31
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
30HaematotoxicityFAERS: 30
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
31Adverse eventFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
32Full blood count decreasedFAERS: 29
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
33Acute kidney injuryFAERS: 28US FAERS
34Myocardial InfarctionFAERS: 28
Canada Vigilance: 3
Canada Vigilance
US FAERS
35treatment failureFAERS: 27US FAERS
36Blood product transfusion dependentFAERS: 26OFFSIDES
US FAERS
37HypotensionFAERS: 26SIDER
US FAERS
38PericarditisFAERS: 26
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
39EpistaxisFAERS: 24
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
40Injection site painFAERS: 24
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
41SyncopeFAERS: 24SIDER
US FAERS
42DizzinessFAERS: 23SIDER
US FAERS
43Neutropenic sepsisFAERS: 23SIDER
US FAERS
44Pericardial effusionFAERS: 23
Canada Vigilance: 4
Canada Vigilance
US FAERS
45Cardiac ArrestFAERS: 22US FAERS
46ColitisFAERS: 22
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
47Abdominal PainFAERS: 21
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
48Bronchopulmonary AspergillosisFAERS: 21US FAERS
49DehydrationFAERS: 20SIDER
US FAERS
50Diabetes MellitusFAERS: 20US FAERS
51Injection site erythemaFAERS: 20
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
52Pulmonary EmbolismFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
53Weight decreasedFAERS: 20SIDER
US FAERS
54ErythemaFAERS: 19SIDER
US FAERS
55HeadacheFAERS: 19SIDER
US FAERS
56Pyoderma GangrenosumFAERS: 19
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
57Back PainFAERS: 18SIDER
US FAERS
58LeukocytosisFAERS: 18US FAERS
59Atrial FibrillationFAERS: 16
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
60ChillsFAERS: 16SIDER
US FAERS
61Disseminated Intravascular CoagulationFAERS: 16US FAERS
62PainFAERS: 16SIDER
US FAERS
63Skin necrosisFAERS: 16OFFSIDES
US FAERS
64Blood creatinine increasedFAERS: 15US FAERS
65Disease recurrenceFAERS: 15US FAERS
66Lower respiratory tract infectionFAERS: 15US FAERS
67Angina PectorisFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
68Chest PainFAERS: 14
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
69HypoxiaFAERS: 14US FAERS
70Malignant neoplasm progressionFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
71PruritusFAERS: 14
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
72TachycardiaFAERS: 14SIDER
US FAERS
73DementiaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
74DyspepsiaFAERS: 13SIDER
US FAERS
75AppendicitisFAERS: 12OFFSIDES
US FAERS
76BronchitisFAERS: 12SIDER
US FAERS
77CytopeniaFAERS: 12
Canada Vigilance: 42
Canada Vigilance
US FAERS
78GastroenteritisFAERS: 12US FAERS
79NasopharyngitisFAERS: 12SIDER
US FAERS
80Deep Vein ThrombosisFAERS: 11US FAERS
81Gastrointestinal toxicityFAERS: 11OFFSIDES
US FAERS
82Graft versus host disease in gastrointestinal tractFAERS: 11US FAERS
83MyelofibrosisFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
84Pulmonary sepsisFAERS: 11US FAERS
85ShockFAERS: 11SIDER
US FAERS
86Skin reactionFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
87Unevaluable eventFAERS: 11US FAERS
88AscitesFAERS: 10US FAERS
89Blast cell count increasedFAERS: 10OFFSIDES
US FAERS
90Cerebral InfarctionFAERS: 10US FAERS
91InfluenzaFAERS: 10US FAERS
92PneumonitisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
93TuberculosisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
94Acute myocardial infarctionFAERS: 9OFFSIDES
US FAERS
95Anal abscessFAERS: 9OFFSIDES
US FAERS
96Complications of transplant surgeryFAERS: 9US FAERS
97DiverticulitisFAERS: 9OFFSIDES
SIDER
US FAERS
98DysgeusiaFAERS: 9US FAERS
99EmbolismFAERS: 9OFFSIDES
US FAERS
100Febrile bone marrow aplasiaFAERS: 9OFFSIDES
US FAERS
101ImmunosuppressionFAERS: 9US FAERS
102UrticariaFAERS: 9
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
103AgranulocytosisFAERS: 8SIDER
US FAERS
104ArthralgiaFAERS: 8SIDER
US FAERS
105AspergillosisFAERS: 8OFFSIDES
US FAERS
106CachexiaFAERS: 8US FAERS
107DeafnessFAERS: 8US FAERS
108Drug toxicityFAERS: 8US FAERS
109Gastrointestinal infectionFAERS: 8US FAERS
110InflammationFAERS: 8SIDER
US FAERS
111Skin toxicityFAERS: 8US FAERS
112SomnolenceFAERS: 8US FAERS
113StomatitisFAERS: 82410119CTD
SIDER
US FAERS
114Urinary RetentionFAERS: 8US FAERS
115Clostridium difficile colitisFAERS: 7US FAERS
116DeliriumFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
117Ejection Fraction DecreasedFAERS: 7US FAERS
118Erythema MultiformeFAERS: 7US FAERS
119HepatotoxicityFAERS: 7US FAERS
120HypersensitivityFAERS: 7SIDER
US FAERS
121Injection site abscessFAERS: 7US FAERS
122Injection site necrosisFAERS: 7SIDER
US FAERS
123Injection site noduleFAERS: 7
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
124Intestinal ObstructionFAERS: 7OFFSIDES
US FAERS
125PhlebitisFAERS: 7OFFSIDES
US FAERS
126RhabdomyolysisFAERS: 78832525CTD
US FAERS
127Skin UlcerFAERS: 7US FAERS
128SplenomegalyFAERS: 7SIDER
US FAERS
129SubileusFAERS: 7US FAERS
130Sudden deathFAERS: 7US FAERS
131SwellingFAERS: 7US FAERS
132ThrombocytosisFAERS: 7US FAERS
133VasculitisFAERS: 7US FAERS
134nervous system disorderFAERS: 7SIDER
US FAERS
135Alanine Aminotransferase IncreasedFAERS: 6US FAERS
136AlopeciaFAERS: 6SIDER
US FAERS
137AtelectasisFAERS: 6SIDER
US FAERS
138Blood lactate dehydrogenase increasedFAERS: 6US FAERS
139BronchopneumoniaFAERS: 6US FAERS
140BursitisFAERS: 6US FAERS
141CholestasisFAERS: 6US FAERS
142Depressed Level of ConsciousnessFAERS: 6US FAERS
143EndocarditisFAERS: 6OFFSIDES
US FAERS
144ExtravasationFAERS: 6US FAERS
145Graft versus host disease in liverFAERS: 6US FAERS
146Histiocytosis haematophagicFAERS: 6US FAERS
147IleusFAERS: 6US FAERS
148Injection site cellulitisFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
149Injection site infectionFAERS: 6
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
150Neutropenic infectionFAERS: 6OFFSIDES
US FAERS
151Performance status decreasedFAERS: 6OFFSIDES
US FAERS
152Pseudomonal sepsisFAERS: 6OFFSIDES
US FAERS
153Pulmonary FibrosisFAERS: 6US FAERS
154SinusitisFAERS: 6SIDER
US FAERS
155ThrombosisFAERS: 6US FAERS
156pseudomembranous colitisFAERS: 6US FAERS
157AbscessFAERS: 5
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
158Acute graft versus host disease in intestineFAERS: 5US FAERS
159Anal FissureFAERS: 5OFFSIDES
US FAERS
160ArthritisFAERS: 5US FAERS
161Aspartate Aminotransferase IncreasedFAERS: 5US FAERS
162Bacterial sepsisFAERS: 5US FAERS
163BlindnessFAERS: 5US FAERS
164Blood alkaline phosphatase increasedFAERS: 5US FAERS
165Blood count abnormalFAERS: 5US FAERS
166Blood iron increasedFAERS: 5OFFSIDES
US FAERS
167Blood urea increasedFAERS: 5US FAERS
168Bone marrow necrosisFAERS: 5US FAERS
169Bone painFAERS: 5OFFSIDES
SIDER
US FAERS
170CholangitisFAERS: 5US FAERS
171Decreased immune responsivenessFAERS: 5US FAERS
172ErysipelasFAERS: 5OFFSIDES
US FAERS
173Erythema NodosumFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
174FibrosisFAERS: 5US FAERS
175Large intestine perforationFAERS: 5US FAERS
176Liver AbscessFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
177LymphopeniaFAERS: 5US FAERS
178Medication ErrorFAERS: 5US FAERS
179OsteomyelitisFAERS: 5US FAERS
180Pancreatic carcinomaFAERS: 5US FAERS
181PetechiaeFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
182PharyngitisFAERS: 5SIDER
US FAERS
183PolychondritisFAERS: 5US FAERS
184Product quality issueFAERS: 5US FAERS
185Pseudoradicular syndromeFAERS: 5US FAERS
186Retinal DetachmentFAERS: 5US FAERS
187Skin lesionFAERS: 5SIDER
US FAERS
188ToxoplasmosisFAERS: 5SIDER
US FAERS
189Troponin increasedFAERS: 5US FAERS
190jaundiceFAERS: 5US FAERS
191Accidental exposureFAERS: 4US FAERS
192Acute promyelocytic leukaemia differentiation syndromeFAERS: 4US FAERS
193Acute respiratory failureFAERS: 4US FAERS
194ArthropathyFAERS: 4US FAERS
195CholecystitisFAERS: 4SIDER
US FAERS
196CystitisFAERS: 4US FAERS
197Cytolytic hepatitisFAERS: 4US FAERS
198Device related infectionFAERS: 4OFFSIDES
US FAERS
199DisorientationFAERS: 4US FAERS
200EpilepsyFAERS: 4US FAERS
201Escherichia infectionFAERS: 4OFFSIDES
US FAERS
202Febrile infectionFAERS: 4OFFSIDES
US FAERS
203Feeling abnormalFAERS: 4SIDER
US FAERS
204Graft versus host disease in skinFAERS: 4US FAERS
205HepatomegalyFAERS: 4US FAERS
206InfarctionFAERS: 4US FAERS
207Injection site irritationFAERS: 4US FAERS
208Injection site vesiclesFAERS: 4US FAERS
209Lymphocyte count decreasedFAERS: 4US FAERS
210MonocytosisFAERS: 4US FAERS
211Muscle RigidityFAERS: 4US FAERS
212MyalgiaFAERS: 4SIDER
US FAERS
213PleurisyFAERS: 4US FAERS
214PolyneuropathyFAERS: 4OFFSIDES
US FAERS
215PresyncopeFAERS: 4US FAERS
216Product use issueFAERS: 4US FAERS
217Pulmonary toxicityFAERS: 4US FAERS
218Soft Tissue InfectionFAERS: 4OFFSIDES
US FAERS
219Splenic RuptureFAERS: 4US FAERS
220Supraventricular tachycardiaFAERS: 4US FAERS
221Thrombocytopenic purpuraFAERS: 4US FAERS
222Transaminases increasedFAERS: 4US FAERS
223TremorFAERS: 4US FAERS
224Acute Coronary SyndromeFAERS: 3US FAERS
225Acute Lung InjuryFAERS: 3US FAERS
226Acute graft versus host disease in liverFAERS: 3OFFSIDES
US FAERS
227Administration site reactionFAERS: 3US FAERS
228AgitationFAERS: 3US FAERS
229Altered state of consciousnessFAERS: 3US FAERS
230AneurysmFAERS: 3US FAERS
231AngioedemaFAERS: 3US FAERS
232Anorectal infectionFAERS: 3OFFSIDES
US FAERS
233Atrial FlutterFAERS: 3OFFSIDES
US FAERS
234Atypical pneumoniaFAERS: 3US FAERS
235Blastic plasmacytoid dendritic cell neoplasiaFAERS: 3US FAERS
236Blood blisterFAERS: 3US FAERS
237BradycardiaFAERS: 3US FAERS
238Cardiac TamponadeFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
239Chemical burns of eyeFAERS: 3OFFSIDES
US FAERS
240Completed SuicideFAERS: 3US FAERS
241Concomitant disease aggravatedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
242CystFAERS: 3SIDER
US FAERS
243Diffuse Large B-Cell LymphomaFAERS: 3US FAERS
244DiscomfortFAERS: 3SIDER
US FAERS
245EcchymosisFAERS: 3SIDER
US FAERS
246Electrolyte imbalanceFAERS: 3US FAERS
247EnteritisFAERS: 3US FAERS
248Epstein-Barr virus associated lymphoproliferative disorderFAERS: 3US FAERS
249Gamma-Glutamyltransferase IncreasedFAERS: 3US FAERS
250Gastric ulcerFAERS: 3US FAERS
251GastritisFAERS: 3US FAERS
252General physical condition abnormalFAERS: 3US FAERS
253Hepatic InfectionFAERS: 3OFFSIDES
US FAERS
254Hepatitis BFAERS: 3OFFSIDES
US FAERS
255HydrocephalusFAERS: 3US FAERS
256Intestinal PerforationFAERS: 3OFFSIDES
US FAERS
257LethargyFAERS: 3SIDER
US FAERS
258Leukaemic infiltration brainFAERS: 3US FAERS
259LeukoencephalopathyFAERS: 3OFFSIDES
US FAERS
260Lung consolidationFAERS: 3US FAERS
261Memory impairmentFAERS: 3US FAERS
262Metastatic NeoplasmFAERS: 3SIDER
US FAERS
263Musculoskeletal PainFAERS: 3SIDER
US FAERS
264MyositisFAERS: 3US FAERS
265NephrolithiasisFAERS: 3US FAERS
266Night sweatsFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
267Osteonecrosis of JawFAERS: 3US FAERS
268OverdoseFAERS: 3US FAERS
269PanniculitisFAERS: 3US FAERS
270ParotitisFAERS: 3US FAERS
271Peripheral swellingFAERS: 3SIDER
US FAERS
272Post procedural complicationFAERS: 3US FAERS
273Product physical issueFAERS: 3US FAERS
274PurpuraFAERS: 3SIDER
US FAERS
275PyelonephritisFAERS: 3OFFSIDES
US FAERS
276Renal tubular acidosisFAERS: 3SIDER
US FAERS
277Rheumatic disorderFAERS: 3US FAERS
278Right ventricular failureFAERS: 3US FAERS
279SarcomaFAERS: 32408741CTD
US FAERS
280Sinusitis aspergillusFAERS: 3US FAERS
281Soft tissue necrosisFAERS: 3OFFSIDES
US FAERS
282Splenic InfarctionFAERS: 3US FAERS
283Stem cell transplantFAERS: 3US FAERS
284Suicide attemptFAERS: 3US FAERS
285Systemic mycosisFAERS: 3US FAERS
286ToothacheFAERS: 3US FAERS
287TracheobronchitisFAERS: 3US FAERS
288Upper respiratory tract inflammationFAERS: 3US FAERS
289Urinary IncontinenceFAERS: 3US FAERS
290Venous ThrombosisFAERS: 3US FAERS
291Visual ImpairmentFAERS: 3US FAERS
292Abdominal AbscessFAERS: 2OFFSIDES
US FAERS
293Accidental exposure to productFAERS: 2US FAERS
294AcidosisFAERS: 2US FAERS
295Acute graft versus host disease in skinFAERS: 2US FAERS
296AgeusiaFAERS: 2US FAERS
297AmyloidosisFAERS: 2US FAERS
298Anal FistulaFAERS: 2US FAERS
299AnuriaFAERS: 2US FAERS
300Aortic AneurysmFAERS: 2US FAERS
301Aortic Valve StenosisFAERS: 2US FAERS
302Aphthous StomatitisFAERS: 2US FAERS
303Arterial thrombosisFAERS: 2OFFSIDES
US FAERS
304AsthmaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
305AtaxiaFAERS: 2US FAERS
306Axonal neuropathyFAERS: 2OFFSIDES
US FAERS
307Basal cell carcinomaFAERS: 2OFFSIDES
US FAERS
308Blood potassium increasedFAERS: 2US FAERS
309Bone marrow reticulin fibrosisFAERS: 2US FAERS
310Bone marrow toxicityFAERS: 2US FAERS
311BronchospasmFAERS: 2US FAERS
312CandidiasisFAERS: 2US FAERS
313CardiomegalyFAERS: 2US FAERS
314Complications of bone marrow transplantFAERS: 2US FAERS
315ConjunctivitisFAERS: 2US FAERS
316Dermatitis acneiformFAERS: 2US FAERS
317Diabetes InsipidusFAERS: 2OFFSIDES
US FAERS
318Diabetes mellitus inadequate controlFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
319Diverticular perforationFAERS: 2US FAERS
320Drug dose omissionFAERS: 2US FAERS
321Drug effect incompleteFAERS: 2US FAERS
322Dry skinFAERS: 2SIDER
US FAERS
323DysuriaFAERS: 2OFFSIDES
SIDER
US FAERS
324EncephalitisFAERS: 2US FAERS
325Enterococcal infectionFAERS: 2US FAERS
326Eosinophilic PneumoniaFAERS: 2US FAERS
327Epstein-Barr virus associated lymphomaFAERS: 2US FAERS
328Extranodal marginal zone B-cell lymphoma (MALT type)FAERS: 2US FAERS
329FlatulenceFAERS: 2US FAERS
330Fluid overloadFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
331Gastrointestinal hypomotilityFAERS: 2US FAERS
332Gastrointestinal inflammationFAERS: 2OFFSIDES
US FAERS
333Gingival HypertrophyFAERS: 2OFFSIDES
US FAERS
334GlycosuriaFAERS: 26160887CTD
US FAERS
335GoutFAERS: 2US FAERS
336Granulocytes abnormalFAERS: 2US FAERS
337Hepatitis CFAERS: 2US FAERS
338Incorrect dose administeredFAERS: 2US FAERS
339IndurationFAERS: 2SIDER
US FAERS
340Infusion site phlebitisFAERS: 2US FAERS
341Injection site bruisingFAERS: 2SIDER
US FAERS
342Injection site exfoliationFAERS: 2US FAERS
343Injection site massFAERS: 2US FAERS
344Injection site vasculitisFAERS: 2US FAERS
345Iron OverloadFAERS: 2OFFSIDES
US FAERS
346Joint swellingFAERS: 2US FAERS
347LaryngitisFAERS: 2US FAERS
348Lobar PneumoniaFAERS: 2US FAERS
349Local reactionFAERS: 2US FAERS
350Lung AbscessFAERS: 2US FAERS
351Lymph Node TuberculosisFAERS: 2US FAERS
352LymphangitisFAERS: 2US FAERS
353LymphomaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
354Meningitis herpesFAERS: 2US FAERS
355MeningitisFAERS: 2US FAERS
356Metabolic acidosisFAERS: 2US FAERS
357MetastasisFAERS: 2US FAERS
358MonoplegiaFAERS: 2US FAERS
359Musculoskeletal stiffnessFAERS: 2US FAERS
360MyocarditisFAERS: 2US FAERS
361Neck PainFAERS: 2SIDER
US FAERS
362NecrosisFAERS: 2US FAERS
363Nephrotic SyndromeFAERS: 2US FAERS
364Neuropsychiatric syndromeFAERS: 2US FAERS
365NoduleFAERS: 2SIDER
US FAERS
366OliguriaFAERS: 2US FAERS
367Oral candidiasisFAERS: 2US FAERS
368Oral infectionFAERS: 2OFFSIDES
US FAERS
369Oropharyngeal candidiasisFAERS: 2US FAERS
370Oropharyngeal painFAERS: 2US FAERS
371PancreatitisFAERS: 2US FAERS
372ParaplegiaFAERS: 2OFFSIDES
US FAERS
373PeritonitisFAERS: 2US FAERS
374Platelet count abnormalFAERS: 2US FAERS
375PneumothoraxFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
376Procedural complicationFAERS: 2US FAERS
377Product reconstitution quality issueFAERS: 2US FAERS
378Pulmonary HypertensionFAERS: 2US FAERS
379Pulmonary arterial hypertensionFAERS: 2US FAERS
380Pulmonary thrombosisFAERS: 2US FAERS
381Refractory cytopenia with multilineage dysplasiaFAERS: 2US FAERS
382Retinal Artery OcclusionFAERS: 2US FAERS
383RhinitisFAERS: 2SIDER
US FAERS
384Septic embolusFAERS: 2US FAERS
385Skeletal injuryFAERS: 2US FAERS
386Skin irritationFAERS: 2US FAERS
387Splenic abscessFAERS: 2US FAERS
388StressFAERS: 2US FAERS
389Sudden Cardiac DeathFAERS: 2US FAERS
390Therapy cessationFAERS: 2US FAERS
391ThrombophlebitisFAERS: 2US FAERS
392Transplantation complicationFAERS: 2US FAERS
393Troponin I increasedFAERS: 2US FAERS
394UlcerFAERS: 2US FAERS
395Ventricular FibrillationFAERS: 2US FAERS
396VertigoFAERS: 2US FAERS
397Viral pericarditisFAERS: 2OFFSIDES
US FAERS
398Vocal Cord ParalysisFAERS: 2US FAERS
399Wound InfectionFAERS: 2US FAERS
400Abdominal discomfortFAERS: 1OFFSIDES
US FAERS
401Accidental deathFAERS: 1US FAERS
402Accidental overdoseFAERS: 1US FAERS
403AcneFAERS: 1US FAERS
404Acquired diaphragmatic eventrationFAERS: 1US FAERS
405Acquired gene mutationFAERS: 1US FAERS
406Acute polyneuropathyFAERS: 1US FAERS
407Administration site bruiseFAERS: 1US FAERS
408Administration site erythemaFAERS: 1US FAERS
409Air EmbolismFAERS: 1US FAERS
410AmnesiaFAERS: 1US FAERS
411Anal UlcerFAERS: 1US FAERS
412Anal inflammationFAERS: 1US FAERS
413Anastomotic complicationFAERS: 1US FAERS
414AngiodysplasiaFAERS: 1US FAERS
415Angioimmunoblastic T-cell lymphoma refractoryFAERS: 1US FAERS
416Ankle FractureFAERS: 1US FAERS
417AnorexiaFAERS: 1SIDER
US FAERS
418AnxietyFAERS: 1SIDER
US FAERS
419AortitisFAERS: 1US FAERS
420AphasiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
421Application site infectionFAERS: 1US FAERS
422Application site inflammationFAERS: 1US FAERS
423Application site injuryFAERS: 1US FAERS
424Application site reactionFAERS: 1US FAERS
425Arteriovenous fistula thrombosisFAERS: 1US FAERS
426ArteritisFAERS: 1US FAERS
427AsphyxiaFAERS: 1US FAERS
428Bacillus infectionFAERS: 1US FAERS
429Back disorderFAERS: 1US FAERS
430BedriddenFAERS: 1US FAERS
431Blood albumin decreasedFAERS: 1US FAERS
432Blood amylase increasedFAERS: 1US FAERS
433Blood creatine phosphokinase increasedFAERS: 1US FAERS
434Blood glucose decreasedFAERS: 1US FAERS
435Blood magnesium decreasedFAERS: 1US FAERS
436Blood pH decreasedFAERS: 1US FAERS
437Blood potassium abnormalFAERS: 1US FAERS
438Blood potassium decreasedFAERS: 1US FAERS
439Blood stem cell transplant failureFAERS: 1US FAERS
440Blood uric acid abnormalFAERS: 1US FAERS
441Blood urine presentFAERS: 1US FAERS
442Brain AbscessFAERS: 1US FAERS
443Breast cancer recurrentFAERS: 1US FAERS
444Bronchial ObstructionFAERS: 1OFFSIDES
US FAERS
445Candida sepsisFAERS: 1US FAERS
446Candida test positiveFAERS: 1US FAERS
447Cardiac DeathFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
448Cardiac dysfunctionFAERS: 1US FAERS
449Cardiac valve abscessFAERS: 1US FAERS
450Cardiomyopathy acuteFAERS: 1US FAERS
451Cardiovascular insufficiencyFAERS: 1US FAERS
452CataractFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
453Catheter site erythemaFAERS: 1SIDER
US FAERS
454Catheter site infectionFAERS: 1US FAERS
455Catheter site necrosisFAERS: 1US FAERS
456Catheter site painFAERS: 1US FAERS
457Catheter site related reactionFAERS: 1US FAERS
458Catheter site warmthFAERS: 1US FAERS
459Central Nervous System InfectionFAERS: 1US FAERS
460Central nervous system lesionFAERS: 1US FAERS
461Cerebral ThrombosisFAERS: 1US FAERS
462Chest discomfortFAERS: 1US FAERS
463ChimerismFAERS: 1US FAERS
464CholelithiasisFAERS: 1US FAERS
465Citrobacter infectionFAERS: 1US FAERS
466ClonusFAERS: 1US FAERS
467Clostridium difficile infectionFAERS: 1US FAERS
468Compression fractureFAERS: 1OFFSIDES
US FAERS
469Cor pulmonaleFAERS: 1US FAERS
470Deafness NeurosensoryFAERS: 1US FAERS
471Device dislocationFAERS: 1US FAERS
472Device related sepsisFAERS: 1US FAERS
473Diabetic FootFAERS: 1US FAERS
474Diabetic foot infectionFAERS: 1US FAERS
475Drug dispensing errorFAERS: 1US FAERS
476Drug exposure via breast milkFAERS: 1US FAERS
477DysarthriaFAERS: 1US FAERS
478DysphoniaFAERS: 1US FAERS
479Early satietyFAERS: 1US FAERS
480Emotional distressFAERS: 1US FAERS
481EmpyemaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
482EnterocolitisFAERS: 1OFFSIDES
US FAERS
483Enzyme abnormalityFAERS: 1US FAERS
484EosinophiliaFAERS: 1US FAERS
485ErythroblastosisFAERS: 1US FAERS
486Escherichia sepsisFAERS: 1OFFSIDES
US FAERS
487Extremity necrosisFAERS: 1US FAERS
488Eye painFAERS: 1OFFSIDES
US FAERS
489Eyelid painFAERS: 1US FAERS
490Facial ParesisFAERS: 1US FAERS
491Facial paralysisFAERS: 1US FAERS
492Factor V inhibitionFAERS: 1US FAERS
493Fat necrosisFAERS: 1US FAERS
494Foreign body sensation in eyesFAERS: 1US FAERS
495FractureFAERS: 1US FAERS
496GanglioneuromaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
497Gas GangreneFAERS: 1US FAERS
498Gastrointestinal carcinomaFAERS: 1US FAERS
499Gastrointestinal obstructionFAERS: 1US FAERS
500General symptomFAERS: 1US FAERS
501Genital HerpesFAERS: 1US FAERS
502Genital abscessFAERS: 1US FAERS
503Genitourinary tract infectionFAERS: 1US FAERS
504GingivitisFAERS: 1US FAERS
505GlaucomaFAERS: 1OFFSIDES
US FAERS
506GlioblastomaFAERS: 1US FAERS
507GlomerulonephritisFAERS: 1US FAERS
508GlossitisFAERS: 1US FAERS
509Guillain-Barre SyndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
510HemiplegiaFAERS: 1US FAERS
511Hepatic cancer metastaticFAERS: 1US FAERS
512Hepatitis EFAERS: 1US FAERS
513HidradenitisFAERS: 1US FAERS
514Hospice CareFAERS: 1US FAERS
515HyperpyrexiaFAERS: 1US FAERS
516Hypertensive crisisFAERS: 1US FAERS
517HyperthyroidismFAERS: 1US FAERS
518Hyperviscosity syndromeFAERS: 1US FAERS
519HypomaniaFAERS: 1US FAERS
520HypoperfusionFAERS: 1US FAERS
521HypopituitarismFAERS: 1US FAERS
522Ileal StenosisFAERS: 1US FAERS
523Impaired driving abilityFAERS: 1US FAERS
524Impaired self-careFAERS: 1US FAERS
525Inappropriate schedule of drug administrationFAERS: 1US FAERS
526IncontinenceFAERS: 1US FAERS
527Incorrect route of drug administrationFAERS: 1US FAERS
528Infectious colitisFAERS: 1US FAERS
529Infusion site pruritusFAERS: 1US FAERS
530Infusion site reactionFAERS: 1US FAERS
531Injection site dermatitisFAERS: 1SIDER
US FAERS
532Injection site discomfortFAERS: 1US FAERS
533Injection site inflammationFAERS: 1US FAERS
534Injection site streakingFAERS: 1US FAERS
535Injection site ulcerFAERS: 1US FAERS
536Janus kinase 2 mutationFAERS: 1US FAERS
537Jejunal ulcerFAERS: 1US FAERS
538Jugular vein occlusionFAERS: 1US FAERS
539Leptotrichia infectionFAERS: 1US FAERS
540Limb injuryFAERS: 1US FAERS
541Limbic EncephalitisFAERS: 1US FAERS
542Lip and/or oral cavity cancerFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
543Lipodystrophy acquiredFAERS: 1US FAERS
544ListeriosisFAERS: 1US FAERS
545Lower respiratory tract infection fungalFAERS: 1US FAERS
546Lung infection pseudomonalFAERS: 1US FAERS
547Lung squamous cell carcinoma stage IVFAERS: 1US FAERS
548LymphadenopathyFAERS: 1SIDER
US FAERS
549MaculeFAERS: 1US FAERS
550MalabsorptionFAERS: 1US FAERS
551MalnutritionFAERS: 1SIDER
US FAERS
552Mantle cell lymphomaFAERS: 1US FAERS
553Metapneumovirus infectionFAERS: 1US FAERS
554Monocyte count decreasedFAERS: 1US FAERS
555Monocyte count increasedFAERS: 1US FAERS
556MucormycosisFAERS: 1US FAERS
557Myasthenic SyndromeFAERS: 1US FAERS
558MyopericarditisFAERS: 1US FAERS
559Nasal discomfortFAERS: 1US FAERS
560Nephrogenic Diabetes InsipidusFAERS: 1US FAERS
561NeuralgiaFAERS: 1US FAERS
562Neutropenic colitisFAERS: 1US FAERS
563Neutrophilic panniculitisFAERS: 1US FAERS
564No adverse eventFAERS: 1US FAERS
565Nodular vasculitisFAERS: 1US FAERS
566ObesityFAERS: 1US FAERS
567Optic NeuropathyFAERS: 1OFFSIDES
US FAERS
568Oral painFAERS: 1US FAERS
569Oral pustuleFAERS: 1US FAERS
570OsteolysisFAERS: 1US FAERS
571PO2 decreasedFAERS: 1US FAERS
572PalpitationsFAERS: 1US FAERS
573Pancreatic CystFAERS: 1US FAERS
574ParaparesisFAERS: 1US FAERS
575PemphigusFAERS: 1US FAERS
576Peptic UlcerFAERS: 1US FAERS
577Periorbital abscessFAERS: 1US FAERS
578Periorbital disorderFAERS: 1US FAERS
579Peripheral artery thrombosisFAERS: 1US FAERS
580Perirectal abscessFAERS: 1SIDER
US FAERS
581Peritonsillar AbscessFAERS: 1US FAERS
582Philadelphia chromosome positiveFAERS: 1US FAERS
583Platelet TransfusionFAERS: 1US FAERS
584Pleuritic painFAERS: 1US FAERS
585Pneumococcal sepsisFAERS: 1US FAERS
586PolyarthritisFAERS: 1US FAERS
587Post procedural infectionFAERS: 1US FAERS
588Postoperative ileusFAERS: 1US FAERS
589Pregnancy of partnerFAERS: 1US FAERS
590Product administration errorFAERS: 1US FAERS
591Product formulation issueFAERS: 1US FAERS
592Product packaging confusionFAERS: 1US FAERS
593Product packaging issueFAERS: 1US FAERS
594Product packaging quantity issueFAERS: 1US FAERS
595Productive CoughFAERS: 1OFFSIDES
SIDER
US FAERS
596Protein total decreasedFAERS: 1US FAERS
597PsoriasisFAERS: 1US FAERS
598Pulmonary congestionFAERS: 1US FAERS
599Pulmonary granulomaFAERS: 1US FAERS
600Pure white cell aplasiaFAERS: 1US FAERS
601RalesFAERS: 1SIDER
US FAERS
602Rash erythematousFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
603Renal ColicFAERS: 1US FAERS
604Renal cystFAERS: 1US FAERS
605Renal tubular disorderFAERS: 1US FAERS
606Respiratory arrestFAERS: 1US FAERS
607Respiratory distressFAERS: 1SIDER
US FAERS
608Respiratory tract infection fungalFAERS: 1US FAERS
609RestlessnessFAERS: 1US FAERS
610Retinal Vein OcclusionFAERS: 1US FAERS
611Retinal toxicityFAERS: 1US FAERS
612Retinal vascular thrombosisFAERS: 1US FAERS
613RhinalgiaFAERS: 1US FAERS
614Rhinovirus infectionFAERS: 1US FAERS
615SarcoidosisFAERS: 1US FAERS
616ScabFAERS: 1US FAERS
617Scedosporium infectionFAERS: 1US FAERS
618Secretion dischargeFAERS: 1US FAERS
619Seminal vesiculitisFAERS: 1US FAERS
620Severe Acute Respiratory SyndromeFAERS: 1US FAERS
621Sick Sinus SyndromeFAERS: 1US FAERS
622Sinus TachycardiaFAERS: 1US FAERS
623Spinal column stenosisFAERS: 1US FAERS
624Stenotrophomonas infectionFAERS: 1US FAERS
625Subcutaneous AbscessFAERS: 1US FAERS
626SuperinfectionFAERS: 1US FAERS
627Systemic Inflammatory Response SyndromeFAERS: 1SIDER
US FAERS
628TachyarrhythmiaFAERS: 1US FAERS
629Tardive DyskinesiaFAERS: 1US FAERS
630Terminal stateFAERS: 1US FAERS
631Therapeutic response unexpectedFAERS: 1US FAERS
632Thermal burnFAERS: 1US FAERS
633Throat irritationFAERS: 1US FAERS
634Thyroid cancer metastaticFAERS: 1US FAERS
635Tooth InfectionFAERS: 1US FAERS
636Transfusion ReactionFAERS: 1OFFSIDES
SIDER
US FAERS
637Transfusion-Related Acute Lung InjuryFAERS: 1US FAERS
638TransplantFAERS: 1US FAERS
639Unresponsive to stimuliFAERS: 1US FAERS
640Urinary tract infection fungalFAERS: 1US FAERS
641Urinary tract infection pseudomonalFAERS: 1US FAERS
642Urinary tract obstructionFAERS: 1US FAERS
643VIIth nerve paralysisFAERS: 1US FAERS
644Vasoplegia syndromeFAERS: 1US FAERS
645Venoocclusive diseaseFAERS: 1US FAERS
646Ventricular FlutterFAERS: 1US FAERS
647Vulvar erosionFAERS: 1US FAERS
648Vulvovaginal painFAERS: 1US FAERS
649Wrong technique in product usage processFAERS: 1US FAERS
650ZygomycosisFAERS: 1US FAERS
651prostatitisFAERS: 1US FAERS
652Abdominal InfectionCanada Vigilance: 1Canada Vigilance
653Abdominal sepsisOFFSIDES
654Abdominal tendernessSIDER
655Abnormalities, Drug-Induced2467392CTD
656Abscess soft tissueCanada Vigilance: 1Canada Vigilance
657Acute prerenal failureOFFSIDES
658AgraphiaOFFSIDES
659Anaemia NOS aggravatedSIDER
660Anaphylactic shockSIDER
661Anencephaly11875660CTD
662Anorectal cellulitisOFFSIDES
663Anti-erythropoietin antibody positiveOFFSIDES
664ApneaOFFSIDES
665AsbestosisOFFSIDES
666Atrial tachycardiaOFFSIDES
667Bacterial culture positiveOFFSIDES
668Birth Weight70373CTD
669Blast cell count decreasedOFFSIDES
670BlastomycosisSIDER
671BlepharospasmOFFSIDES
672Blood Coagulation Disorders26712470CTD
673Blood GlucoseOFFSIDES
674Blood and lymphatic system disordersSIDER
675Blood erythropoietin increasedOFFSIDES
676Blood immunoglobulin A increasedOFFSIDES
677Bone Marrow Diseases2410119
6178065
CTD
678Bone fistulaOFFSIDES
679Bone marrow depressionSIDER
680Bone pain aggravatedSIDER
681Brain Diseases70373CTD
682Bronchial Neoplasms6209028CTD
683Cardiomyopathies2410119CTD
684Cardiovascular Abnormalities26712470CTD
685Chemical and Drug Induced Liver Injury6178065CTD
686Chest wall painSIDER
687Chronic left ventricular failureOFFSIDES
688Colonic Neoplasms19723570CTD
689Colorectal Neoplasms19934284CTD
690Congenital tricuspid valve incompetenceOFFSIDES
691Decreased LibidoOFFSIDES
692DermatitisSIDER
693Device leakageOFFSIDES
694Diarrhea2410119CTD
695Drug addictOFFSIDES
696Dyspnoea exacerbatedSIDER
697Edema26712470CTD
698Embryo Loss26712470CTD
699EndarterectomyOFFSIDES
700Eye muscle operationOFFSIDES
701Failure to ThriveOFFSIDES
702FasciotomyOFFSIDES
703Fatigue aggravatedSIDER
704Fetal Death2408741CTD
705Fetal Growth Retardation1690922CTD
706Fetal Resorption1690922CTD
707Flank PainOFFSIDES
708Fungal test positiveOFFSIDES
709Gastrointestinal PainSIDER
710General physical conditionOFFSIDES
711GiardiasisOFFSIDES
712GranulocytosisOFFSIDES
713Hyperbilirubinemia2410119CTD
714HypercapniaOFFSIDES
715Hypophosphatemia6160887CTD
716Hypotension, Orthostatic6160887CTD
717Incision site painCanada Vigilance: 1Canada Vigilance
718InfestationSIDER
719Injection site fibrosisOFFSIDES
720Injection site granulomaSIDER
721Injection site pruritusSIDER
722Injection site warmthCanada Vigilance: 1Canada Vigilance
723Intestinal infarctionOFFSIDES
724Joint abscessOFFSIDES
725Kidney Diseases19723570CTD
726Klebsiella sepsisSIDER
727Leukopenia neonatalOFFSIDES
728LeukostasisOFFSIDES
729Lipase abnormalOFFSIDES
730Liver Neoplasms, Experimental17113696CTD
731Loin painSIDER
732Lung Neoplasms2408741
21224363
CTD
733Mammary Neoplasms, Experimental19723570CTD
734Metamyelocyte count increasedOFFSIDES
735Monosomy19299654CTD
736Multiple Myeloma18443271
19549372
CTD
OFFSIDES
737Musculoskeletal chest painSIDER
738Musculoskeletal discomfortSIDER
739MyelodysplasiaOFFSIDES
740Neoplasms, Experimental2408741CTD
741Neoplasms, Multiple Primary6209028CTD
742Neural Tube Defects1690922CTD
743Neuromuscular Diseases6178065CTD
744Nutritional condition abnormalOFFSIDES
745Optic Disc EdemaOFFSIDES
746Oral mucosal petechiaeSIDER
747PallorSIDER
748Pharyngolaryngeal PainSIDER
749Pitting edemaSIDER
750Polyuria6160887
11219485
CTD
751Post procedural painSIDER
752Precancerous Conditions2578334
6208592
6209028
CTD
753Prenatal Exposure Delayed Effects70373CTD
754Prenatal Injuries1690922CTD
755Prostatic Neoplasms18324645CTD
756PrurigoSIDER
757Psychomotor skills impairedOFFSIDES
758PterygiumOFFSIDES
759Red blood cell spherocytes presentOFFSIDES
760RhonchiSIDER
761Sarcoma, Experimental2408741CTD
762ScotomaOFFSIDES
763SigmoiditisOFFSIDES
764Skin IndurationSIDER
765Skin Neoplasms6209028CTD
766Skin neoplasm excisionOFFSIDES
767Skin noduleSIDER
768SnoringOFFSIDES
769Soft Tissue Neoplasms2408741CTD
770Spondylitic myelopathyOFFSIDES
771SporotrichosisOFFSIDES
772Sputum culture positiveOFFSIDES
773Supraventricular tachyarrhythmiaOFFSIDES
774Temporal ArteritisOFFSIDES
775Testicular Neoplasms6209028CTD
776Upper-airway cough syndromeSIDER
777Vascular purpuraSIDER
778Viral upper respiratory tract infectionOFFSIDES
779Vitamin B 12 DeficiencyOFFSIDES
780WheezingSIDER
781Wound closureOFFSIDES
782bone marrow fibrosisOFFSIDES
783leukemia2408741
19148494
CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.